Skip to main content
Equibles
PRVA logo

PRVA · Privia Health Group, Inc. · Documents

Track PRVA — free

Use PRVA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PRVA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$24.55 +0.88 (+3.72%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$3.14B
Shares
127.77M
Volume · Nov 13 1.61M Avg daily vol (3M) 1.26M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $2.12B up 22.3% 10-K filed Feb 27, 2026 Quarterly report FY2026 Q3 Revenue $656.96M up 13.2% 10-Q filed Nov 5, 2026 Latest results Raised 2026 Outlook After Strong Third-Quarter Growth 8-K filed Nov 5, 2026 Earnings call Q3 2026 earnings call Held Nov 5, 2026
2026
Nov 5
Earnings call
Raises outlook, acquires ACO adding more than 36,000 lives

Privia Health raised its 2026 outlook across key financial metrics, targeting 6,000 clinicians and 23.9% adjusted EBITDA growth. It acquired American Choice Healthcare MSSP ACO for approximately $36 million, adding more than 36,000 attributed lives.

4 source passages
Given our strong year-to-date results, we are raising our 2026 outlook above the high end of our initial guidance for all key financial metrics. We expect to reach 6,000 clinicians by year-end, which is 11.5% growth over 2025. The midpoint of our adjusted EBITDA guidance is now above the high end of our initial guide and represents 23.9% growth over last year. This week, we announced the acquisition of American Choice Healthcare MSSP ACO, a wholly-owned subsidiary of K&O Health, approximately $36 million in cash. The Accountable Care Organization is expected to care for more than 36,000 attributed lives, participating in the Medicare Shared Savings Program beginning January of 2027. Open the document at this passage
Nov 5
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue reaches $657.0 million as Adjusted EBITDA rises

Privia Health Group, Inc. reported revenue of $657.0 million and net income attributable to the company of $13.5 million for the three months ended September 30, 2026, versus $580.4 million and $6.9 million in 2025. Adjusted EBITDA rose to $40.6 million from $38.2 million.

Revenue $656.96M ▲ 13.2% Net income $13.49M ▲ 96.6% Diluted EPS $0.10 ▲ 100.0%
Read from the MD&A section
3 source passages
Revenue was $657.0 million and $580.4 million for the three months ended September 30, 2026 and 2025, respectively, and $1.89 billion and $1.58 billion for the nine months ended September 30, 2026 and 2025, respectively; Net income attributable to Privia Health Group, Inc. was $13.5 million and $6.9 million, for the three months ended September 30, 2026 and 2025, respectively, and $25.6 million and $13.8 million for the nine months ended September 30, 2026 and 2025, respectively. Adjusted EBITDA was $40.6 million and $38.2 million for the three months ended September 30, 2026 and 2025, respectively, and $114.7 million and $94.1 million for the nine months ended September 30, 2026 and 2025, respectively. Open the document at this passage
Nov 5
Current report 8-K
Raised 2026 Outlook After Strong Third-Quarter Growth

Privia Health Group, Inc. reported nine-month 2026 net income of $25.6M, up 85.9%, and Adjusted EBITDA of $114.7M, up 21.9%. It raised full-year 2026 guidance above the prior high end for all key metrics.

Financial results
4 source passages
–YTD’26 Net Income of $25.6M, +85.9% from YTD’25 –YTD’26 Adjusted EBITDA of $114.7M, +21.9% from YTD’25 –Full-Year 2026 Guidance Raised to Above High End for All Key Financial Metrics Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the third quarter and nine-month periods ended September 30, 2026. Open the document at this passage
Aug 6
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $632.63M ▲ 21.4% Net income $9.05M ▲ 236.7% Diluted EPS $0.07 ▲ 250.0%
May 7
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $603.85M ▲ 25.8% Net income $3.06M ▼ 27.4% Diluted EPS $0.02 ▼ 33.3%
Apr 2
Proxy statement DEF 14A Meeting May 20, 2026
Proxy statement AI summary on its way
Feb 27
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $2.12B ▲ 22.3% Net income $22.92M ▲ 59.3% Diluted EPS $0.18 ▲ 63.6%
2025
Nov 6
Quarterly report 10-Q FY2025 Q3, ended Sep 30
Quarterly report for FY2025 Q3
Revenue $580.42M ▲ 32.5% Net income $6.86M ▲ 94.1% Diluted EPS $0.05 ▲ 66.7%
Aug 7
Quarterly report 10-Q FY2025 Q2, ended Jun 30
Quarterly report for FY2025 Q2
Revenue $521.15M ▲ 23.4% Net income $2.69M ▼ 22.5% Diluted EPS $0.02 ▼ 33.3%
May 8
Quarterly report 10-Q FY2025 Q1, ended Mar 31
Quarterly report for FY2025 Q1
Revenue $480.1M ▲ 15.6% Net income $4.22M ▲ 41.4% Diluted EPS $0.03 ▲ 50.0%
Feb 27
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $1.74B ▲ 4.7% Net income $14.39M ▼ 37.7% Diluted EPS $0.11 ▼ 42.1%
2024
Nov 7
Quarterly report 10-Q FY2024 Q3, ended Sep 30
Quarterly report for FY2024 Q3
Revenue $437.92M ▲ 4.9% Net income $3.54M ▼ 37.4% Diluted EPS $0.03 ▼ 40.0%
Aug 8
Quarterly report 10-Q FY2024 Q2, ended Jun 30
Quarterly report for FY2024 Q2
Revenue $422.33M ▲ 2.2% Net income $3.47M ▼ 52.3% Diluted EPS $0.03 ▼ 50.0%
Showing 1–50 of 138 documents
Key facts CIK 1759655 CUSIP 74276R102 13F (30d) 233 filings 217 filers Visit website Investor relations